Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Drug Delivery
Pharma
Novartis tasks Lindy to turn biologics into at-home injectables
In a deal worth up to $954 million, Novartis will use Lindy’s suspension technology to design self-administered drugs against multiple targets.
Angus Liu
Aug 28, 2024 10:18am
Orexo's opioid overdose nasal spray is rejected again by FDA
Jul 17, 2024 10:47am
Drugmakers dig in their heels amid FTC's latest patent crackdown
Jun 25, 2024 9:20am
EyePoint reports Duravyu trial fail, raising questions
May 6, 2024 10:55am
FTC targets Novo's Ozempic among 300-plus 'junk' patents
May 1, 2024 7:30am
Roche touts near-complete MS suppression for injectable Ocrevus
Apr 17, 2024 11:00am
